<?xml version="1.0" encoding="UTF-8"?>
<ref id="b36-etm-0-0-8096">
 <label>36</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Belperio</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Dy</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Murray</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Burdick</surname>
    <given-names>MD</given-names>
   </name>
   <name>
    <surname>Xue</surname>
    <given-names>YY</given-names>
   </name>
   <name>
    <surname>Strieter</surname>
    <given-names>RM</given-names>
   </name>
   <name>
    <surname>Keane</surname>
    <given-names>MP</given-names>
   </name>
  </person-group>
  <article-title>The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis</article-title>
  <source>J Immunol</source>
  <volume>173</volume>
  <fpage>4692</fpage>
  <lpage>4698</lpage>
  <year>2004</year>
  <pub-id pub-id-type="doi">10.4049/jimmunol.173.7.4692</pub-id>
  <?supplied-pmid 15383605?>
  <pub-id pub-id-type="pmid">15383605</pub-id>
 </element-citation>
</ref>
